Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists
Status unconfirmed
Conditions studied: Posterior Capsule Opacification Obscuring Vision
In brief
The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.
Key facts
- Study ID
- NCT04027595
- Run by
- Northeastern State University
- People needed
- 200
- Starts
- 2019-09-17
- Expected to finish
- 2022-09-30
- Last updated by the study team
- 2022-09-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ability to provide written informed consent;
- At least 18 years of age, male or female;
- Prior cataract surgery;
- Diagnosed with posterior capsule opacification obstructing vision;
- Best-corrected visual acuity less than 20/40 or visual acuity with glare that reduces by 2 lines or more on an ETDRS visual acuity chart or significant effect on activities of daily living
You may not qualify if…
- History of underlying ocular disease (not including mild/moderate non-proliferative diabetic retinopathy or incidental findings)
- Previous myopic refractive error greater than 6.00 diopters
- Complications following previous ocular procedures (i.e. intraocular lens decentration)
- Ocular surgery other than uncomplicated cataract or uncomplicated refractive surgery
Where it is running
- Northeastern State University — Tahlequah, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.